We've found
3,265
archived clinical trials in
Crohns Disease
We've found
3,265
archived clinical trials in
Crohns Disease
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Updated: 2/22/2013
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Updated: 2/22/2013
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Click here to add this to my saved trials

Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Updated: 2/22/2013
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Updated: 2/22/2013
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Click here to add this to my saved trials

Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Updated: 2/22/2013
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Updated: 2/22/2013
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Click here to add this to my saved trials

Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Updated: 2/22/2013
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Updated: 2/22/2013
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Click here to add this to my saved trials

Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Updated: 2/22/2013
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Updated: 2/22/2013
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Click here to add this to my saved trials

Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Updated: 2/22/2013
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Updated: 2/22/2013
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Click here to add this to my saved trials

Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Updated: 2/22/2013
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Updated: 2/22/2013
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Click here to add this to my saved trials

Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Updated: 2/22/2013
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Updated: 2/22/2013
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Click here to add this to my saved trials

Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Updated: 2/22/2013
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Updated: 2/22/2013
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Click here to add this to my saved trials

Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Updated: 2/22/2013
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Updated: 2/22/2013
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Click here to add this to my saved trials

Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Updated: 2/22/2013
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Updated: 2/22/2013
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Click here to add this to my saved trials

Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Updated: 2/22/2013
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Updated: 2/22/2013
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Click here to add this to my saved trials

Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Updated: 2/22/2013
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Updated: 2/22/2013
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Click here to add this to my saved trials

Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Updated: 2/22/2013
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Updated: 2/22/2013
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Click here to add this to my saved trials

Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Updated: 2/22/2013
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Updated: 2/22/2013
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Click here to add this to my saved trials

Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Updated: 2/22/2013
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Updated: 2/22/2013
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Click here to add this to my saved trials

Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Updated: 2/22/2013
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Updated: 2/22/2013
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Click here to add this to my saved trials

Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Updated: 2/22/2013
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Updated: 2/22/2013
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Click here to add this to my saved trials

Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Updated: 2/22/2013
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Updated: 2/22/2013
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Click here to add this to my saved trials

Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Updated: 2/22/2013
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Updated: 2/22/2013
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Click here to add this to my saved trials

Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Updated: 2/22/2013
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Updated: 2/22/2013
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Click here to add this to my saved trials

Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Updated: 2/22/2013
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Updated: 2/22/2013
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Click here to add this to my saved trials

Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Updated: 2/22/2013
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Updated: 2/22/2013
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Click here to add this to my saved trials

Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Updated: 2/22/2013
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Updated: 2/22/2013
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Click here to add this to my saved trials

Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Updated: 2/22/2013
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Updated: 2/22/2013
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Click here to add this to my saved trials

Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Updated: 2/22/2013
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Updated: 2/22/2013
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Click here to add this to my saved trials

Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Updated: 2/22/2013
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Updated: 2/22/2013
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Click here to add this to my saved trials

Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Updated: 2/22/2013
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Updated: 2/22/2013
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Click here to add this to my saved trials

Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Updated: 2/22/2013
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Updated: 2/22/2013
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Click here to add this to my saved trials

Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Updated: 2/22/2013
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Updated: 2/22/2013
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Click here to add this to my saved trials

Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Updated: 2/22/2013
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Updated: 2/22/2013
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Click here to add this to my saved trials

Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Updated: 2/22/2013
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Updated: 2/22/2013
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Click here to add this to my saved trials

Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Updated: 2/22/2013
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Updated: 2/22/2013
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Click here to add this to my saved trials

Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Updated: 2/22/2013
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Updated: 2/22/2013
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Click here to add this to my saved trials

Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Updated: 2/22/2013
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Updated: 2/22/2013
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Click here to add this to my saved trials

Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Updated: 2/22/2013
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Updated: 2/22/2013
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Click here to add this to my saved trials

Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Updated: 2/22/2013
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Updated: 2/22/2013
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Click here to add this to my saved trials

Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Updated: 2/22/2013
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Updated: 2/22/2013
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Click here to add this to my saved trials

Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Updated: 2/22/2013
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Updated: 2/22/2013
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Click here to add this to my saved trials

Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Updated: 2/22/2013
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Updated: 2/22/2013
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Click here to add this to my saved trials

Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Updated: 2/22/2013
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Updated: 2/22/2013
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Click here to add this to my saved trials

Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Updated: 2/22/2013
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Updated: 2/22/2013
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Click here to add this to my saved trials

Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Updated: 2/22/2013
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Updated: 2/22/2013
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Click here to add this to my saved trials

Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Updated: 2/22/2013
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Updated: 2/22/2013
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Click here to add this to my saved trials

Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Updated: 2/22/2013
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Updated: 2/22/2013
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Click here to add this to my saved trials

Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Updated: 2/22/2013
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Updated: 2/22/2013
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Click here to add this to my saved trials

Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Updated: 2/22/2013
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Updated: 2/22/2013
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Click here to add this to my saved trials

Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Updated: 2/22/2013
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Updated: 2/22/2013
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Click here to add this to my saved trials

Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Updated: 2/22/2013
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Updated: 2/22/2013
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Click here to add this to my saved trials

Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Updated: 2/22/2013
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo
Updated: 2/22/2013
A Phase II Study to Evaluate the Efficacy and Safety of 12 Weeks of Treatment With Oral CNDO 201 Trichuris Suis Ova Suspension (TSO) as Compared to Placebo, Followed by a 12 Week Open-label Treatment Period in Patients With Moderately to Severely Active Crohn's Disease
Status: Enrolling
Updated: 2/22/2013
Click here to add this to my saved trials
